AñadirLa Nacióncomo fuente preferida en

Interés Humano

Vacuna china contra covid-19 llega a Perú para ensayos en voluntarios

Dosis de prueba se inyectarán a 6.000 participantes a partir de la próxima semana

(FILES) In this file photo Dr. Rhonda Flores looks at protein samples at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19. - The Canadian government announced on August 31, 2020 a deal with American biotech firm Novavax for 76 million doses of its Covid-19 vaccine in development, if it proves to be effective against the new coronavirus. The NVX-CoV2373 vaccine candidate, which is currently in Phase 2 clinical trials to evaluate its safety and immunogenicity, could be delivered in the second quarter of 2021, Ottawa and the company said in a joint statement. Procurement Minister Anita Anand said the deal "will give Canadians access to a promising COVID-19 vaccine candidate." (Photo by ANDREW CABALLERO-REYNOLDS / AFP)
(FILES) In this file photo Dr. Rhonda Flores looks at protein samples at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19. - The Canadian government announced on August 31, 2020 a deal with American biotech firm Novavax for 76 million doses of its Covid-19 vaccine in development, if it proves to be effective against the new coronavirus. The NVX-CoV2373 vaccine candidate, which is currently in Phase 2 clinical trials to evaluate its safety and immunogenicity, could be delivered in the second quarter of 2021, Ottawa and the company said in a joint statement. Procurement Minister Anita Anand said the deal "will give Canadians access to a promising COVID-19 vaccine candidate." (Photo by ANDREW CABALLERO-REYNOLDS / AFP) ANDREW CABALLERO-REYNOLDS
AFP
Muestras de proteínas en los laboratorios de Novavax en Gaithersburg, Maryland, el 20 de marzo del 2020, uno de los laboratorios que desarrolla una vacuna para el coronavirus. Foto: AFP (ANDREW CABALLERO-REYNOLDS/AFP)

Lima. Una misión científica china arribó a Lima este miércoles trayendo un lote de vacunas contra el covid-19 que en fase de prueba se inyectará a 6.000 voluntarios peruanos a partir de la semana entrante, informó el gobierno.

El canciller peruano, Mario López, la ministra peruana de Salud, Pilar Mazzetti, y el embajador chino en Lima, Liang Yu, recibieron en el aeropuerto a la misión que coordinará los ensayos clínicos de la vacuna, elaborada por el grupo chino Sinopharm.

‌
‌

‌

‌
‌

‌

‌